-
Autor
Ajayi, Oluseyi F 1 Albanesi, Estela I 1 Alejo, Maria 1 Alemany, Laia 1 Alvarado-Cabrero, Isabel 1 Alòs, Llúcia 1 Benevolo, Maria 1 Biegner, Thorsten 1 Bravo, Ignacio G 1 Cadena, Enrique 1 Castellsagué, Xavier 1 Claros, Edith 1 Clavero, Omar 1 Costes, Valérie 1 Dabed, Pablo 1 Duarte, Flora 1 Duran-Padilla, Marco A 1 Ferrera, Annabelle 1 Félix, Ana 1 Garcia-Rojo, Marcial 1
-
Pracoviště
CIBER Epidemiología y Salud Pública 1 Cancer Epidemiology Research Program Catalan... 1 DDL Diagnostic Laboratory Rijswijk the Nethe... 1 Department of Otorhinolaryngology Faculty of... 1 Department of Pathology University Hospital ... 1 Department of Social and Preventive Medicine... 1 German Cancer Research Center 1 Hospital Clínic University of Barcelona Spain 1 Hospital General de l'Hospitalet L'Hospitale... 1 Hospital Sant Pau Barcelona Spain 1 Hospital de Oncología Centro Médico Nacional... 1 Insituto Oncológico del Oriente Boliviano 1 Institute of Head and Neck Studies and Educa... 1 Instituto Nacional de Cancerología Bogotá Co... 1 Instituto de Investigaciones en Ciencias de ... 1 Laboratorio Clínico y Molecular Hospital SOL... 1 Manchester Royal Infirmary Manchester UK 1 Pathology Department Hospital del Mar IMIM U... 1 Regina Elena National Cancer Institute Rome ... 1 The Fingerland Department of Pathology Charl... 1
- Formát
- Publikační typ
- Check Tag
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
-
Castellsagué, Xavier
Autor Castellsagué, Xavier Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Alemany, Laia
Autor Alemany, Laia Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Quer, Miquel
Autor Quer, Miquel Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Halec, Gordana
Autor Halec, Gordana Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Quirós, Beatriz
Autor Quirós, Beatriz Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Tous, Sara
Autor Tous, Sara Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Clavero, Omar
Autor Clavero, Omar Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Alòs, Llúcia
Autor Alòs, Llúcia Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Biegner, Thorsten
Autor Biegner, Thorsten Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Szafarowski, Tomasz
Autor Szafarowski, Tomasz Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
NLK
Free Medical Journals
od 1996 do Před 1 rokem
Open Access Digital Library
od 1996-01-01
PubMed
26823521
DOI
10.1093/jnci/djv403
Knihovny.cz E-zdroje
BACKGROUND: We conducted a large international study to estimate fractions of head and neck cancers (HNCs) attributable to human papillomavirus (HPV-AFs) using six HPV-related biomarkers of viral detection, transcription, and cellular transformation. METHODS: Formalin-fixed, paraffin-embedded cancer tissues of the oral cavity (OC), pharynx, and larynx were collected from pathology archives in 29 countries. All samples were subject to histopathological evaluation, DNA quality control, and HPV-DNA detection. Samples containing HPV-DNA were further subject to HPV E6*I mRNA detection and to p16(INK4a), pRb, p53, and Cyclin D1 immunohistochemistry. Final estimates of HPV-AFs were based on HPV-DNA, HPV E6*I mRNA, and/or p16(INK4a) results. RESULTS: A total of 3680 samples yielded valid results: 1374 pharyngeal, 1264 OC, and 1042 laryngeal cancers. HPV-AF estimates based on positivity for HPV-DNA, and for either HPV E6*I mRNA or p16(INK4a), were 22.4%, 4.4%, and 3.5% for cancers of the oropharynx, OC, and larynx, respectively, and 18.5%, 3.0%, and 1.5% when requiring simultaneous positivity for all three markers. HPV16 was largely the most common type. Estimates of HPV-AF in the oropharynx were highest in South America, Central and Eastern Europe, and Northern Europe, and lowest in Southern Europe. Women showed higher HPV-AFs than men for cancers of the oropharynx in Europe and for the larynx in Central-South America. CONCLUSIONS: HPV contribution to HNCs is substantial but highly heterogeneous by cancer site, region, and sex. This study, the largest exploring HPV attribution in HNCs, confirms the important role of HPVs in oropharyngeal cancer and drastically downplays the previously reported involvement of HPVs in the other HNCs.
- MeSH
- cyklin D1 analýza MeSH
- DNA virů izolace a purifikace MeSH
- dospělí MeSH
- genotyp MeSH
- imunohistochemie MeSH
- infekce papilomavirem komplikace virologie MeSH
- inhibitor p16 cyklin-dependentní kinasy analýza MeSH
- lidé středního věku MeSH
- lidé MeSH
- lidský papilomavirus 16 izolace a purifikace MeSH
- mezinárodní spolupráce MeSH
- nádorové biomarkery analýza MeSH
- nádorový supresorový protein p53 analýza MeSH
- nádory hlavy a krku virologie MeSH
- nádory orofaryngu chemie virologie MeSH
- Papillomaviridae genetika izolace a purifikace MeSH
- prediktivní hodnota testů MeSH
- průřezové studie MeSH
- senioři MeSH
- slinné proteiny bohaté na prolin analýza MeSH
- spinocelulární karcinom chemie virologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
Upřesnit dle MeSH
Sdílet
Název dokumentu
Po ukončení testovacího provozu bude odkaz přesměrován adresu produkční verze portálu Medvik.